Aeolus Pharma’s AEOL 10150 Declared Orphan Drug for IPF and Lung-ARS
The US FDA recently announced that the experimental drug being developed by Aeolus Pharmaceuticals, Inc. AEOL 10150 has been granted the Orphan Drug status. This […]
Articles by Staff Writer